Please contact us at least 3 weeks before the submission deadline.
This enables us to provide qualitative advice and support.
The open calls are sorted by submission deadline.
IHI – Call 8
IHI call 8 is a two-stage call with topics on cardiovascular disease, osteoarthritis, regulatory sandboxes, and patient-centred endpoints.
Topics
- Topic 1: A city-based approach to reducing cardiovascular mortality in Europe
- Topic 2: Novel endpoints for osteoarthritis (OA) by applying big data analytics
- Topic 3: Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation
- Topic 4: Patient-centred clinical-study endpoints derived using digital health technologies
Deadline: 10 October 2024 (short proposal); 23 April 2025 (full proposal)
EU-ATTRACT 2025: International call for research proposals on rare cancer
EU-ATTRACT 2025: International call for research proposals on rare cancer drug development ATTRACT Cancer drug research
ATTRACT is the first international initiative to accelerate drug development for rare cancers by funding cross-border clinical academic research. Building on the success of the first edition, we are excited to announce the launch of a second call for projects in September 2024.
Six European anticancer charities join forces and launch the ATTRACT 2025 call to stimulate international research on the treatment of rare cancers. We invite European researchers and clinicians from different countries to unite and collaborate in setting up late phase (phase 2/3) international clinical trials that aim to advance the development of better drug therapy for rare cancers patients.
Application open: 09 September 2024
Deadline: 11 October 2024 (pre-proposal); End of April 2025 (full proposal)
KOTK – Emmanuel van der Schueren Fellowships Call 2025
For promising scientists who (want to) conduct highly patient-centred cancer research and/or citizen-centred prevention research and do not receive support from the government and/or industry, Kom op tegen Kanker funds the Emmanuel van der Schueren personal fellowships.
Purpose
We support prevention, psychosocial, translational and clinical research that contributes to the prevention and/or early detection of cancer (prevention), to alleviating (the consequences of) cancer (psychosocial) or to improving the diagnosis or treatment of cancer in applied research (translational and clinical).
To be eligible for funding, the added value for the target group (patients, their environment and/or citizens) should always be central, and the intervention (developed within the project) should already be known.
Basic fundamental research is not eligible.
Budget: 1.33 M euro
Deadline: 24 April 2025
FWO – Call 2025 – Medium-scale and large-scale research infrastructure
Large-scale: Research infrastructure comprises all facilities and sources that promote the performance of cross-border and strategic basic research across all scientific disciplines. Besides scientific infrastructure, this includes collections, natural habitats, corpora and databases (including digital opening up).
Large-scale research infrastructure is defined as research infrastructure with a total subsidy cost excl. co-financing of at least EUR 1,000,000 (including the non-refundable portion of VAT).
Medium-Scale: Research infrastructure comprises all facilities and sources that promote the performance of cross-border and strategic basic research across all scientific disciplines. Besides scientific infrastructure, this includes collections, natural habitats, corpora and databases (including digital opening up).
Medium scale research infrastructure is defined as research infrastructure with a total subsidy cost excl. co-funding of at least EUR 150,000 and at most EUR 1,000,000 (including VAT).
Budget: medium-scale – 150.000 up to 1.000.000 euro / large-scale – > 1.000.000 euro
Deadline: 18 September 2025
KOTK – Call psychosocial projects (including seed money)
KOTK funds psychosocial research and implementation projects that introduce something new in the care of (ex-)cancer patients or substantially improve existing care. Funding can be in the form of seed money or project money.
Deadlines: 13 January 2025, 10 March 2025, 26 May 2025, 25 August 2025, 9 October 2025
FWO – TBM projects (Applied Biomedical Research with a Primary Social finality)
In the long term, the TBM programme aims at contributing to the implementation of (new) therapies, diagnostic techniques and preventive methods, which would not make it to the patient without government funding due to a lack of industrial interest.
Deadline: 14 April 2025 (internal submission) / 22 April 20255 (final submission)
Budget: €215.000 – 850.000
IHI – Call 8: Topics on cardiovascular disease, osteoarthritis, regulatory sandboxes, and patient-centred endpoints
Topics
- Topic 1: A city-based approach to reducing cardiovascular mortality in Europe
- Topic 2: Novel endpoints for osteoarthritis (OA) by applying big data analytics
- Topic 3: Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation
- Topic 4: Patient-centred clinical-study endpoints derived using digital health technologies
Deadline: 10 October 2024 (short proposal); 23 April 2025 (full proposal)
ATTRACT – 2025 International call for research proposals on rare cancer drug development
ATTRACT is the first international initiative to accelerate drug development for rare cancers by funding cross-border clinical academic research. Building on the success of the first edition, we are excited to announce the launch of a second call for projects in September 2024.
Six European anticancer charities join forces and launch the ATTRACT 2025 call to stimulate international research on the treatment of rare cancers. We invite European researchers and clinicians from different countries to unite and collaborate in setting up late phase (phase 2/3) international clinical trials that aim to advance the development of better drug therapy for rare cancers patients.
Deadline: 11 October 2024 (pre-proposal); end of April 2025 (full proposal)
ERDERA – 2025 Call on pre-clinical therapy studies for rare diseases open
The European Partnership on Rare Diseases (ERDERA) has opened its first Joint Transnational Call for Proposals on ‘Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation’.
Deadline: 13 February 2025 (pre-proposal), early May 2025 (full proposal)
King Baudouin Foundation – Fundamental research on the mechanisms of pediatric cancers
The call for fundamental research on the mechanisms of pediatric cancers with clinical translation is launched by the Funds Simon Bauvin, Christian Lispet, Rosa Meynen, Denise Raes and Alice Sepulchre.
The introduced research project aims to improve the understanding of pediatric tumor biology, including (but not limited to) studies on genetic change, signaling pathways and tumor microenvironment. The project should be specific to pediatric cancers and include clear perspectives for applications in medicine.
Collaborations between laboratory scientists and clinicians are strongly encouraged.
Budget: 170.000 euro
Deadline: 22 May 2025
This list is non-exhaustive